The Food and Drug Administration hasn't but cleared Moderna's coronavirus vaccine, opposite to a tweet from President Donald Trump on Friday that mentioned the company had "overwhelmingly approved" it and would instantly distribute it.
The FDA didn't touch upon Trump's tweet, pointing CNBC as a substitute to a Thursday night time assertion from FDA Commissioner Dr. Stephen Hahn that the company would "rapidly work toward finalization and issuance of an emergency use authorization" for Moderna's vaccine.
"The agency has also notified the U.S. Centers for Disease Control and Prevention and Operation Warp Speed, so they can execute their plans for timely vaccine distribution," Hahn mentioned in a joint assertion with Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.
University of Iowa Hospitals CEO on managing two Covid vaccinesSquawk on the Street
The FDA's assertion on Thursday "is current," FDA spokesman Michael Felberbaum advised CNBC after Trump's tweet.
It's doable Trump was referring to a vote Thursday from the FDA's Vaccines and Related Biological Products Advisory Committee, which voted 20-0 with one member abstaining to endorse the approval of Moderna's vaccine for emergency use. The advisory committee performs a key position in approving flu and different vaccines within the U.S., verifying the photographs are protected for public use. While the FDA doesn't should comply with the advisory committee's suggestion, it typically does.
The FDA is predicted to authorize Moderna's vaccine as early as Friday. The U.S. plans to ship slightly below 6 million doses subsequent week, pending the company's approval, Gen. Gustave Perna, who oversees logistics for the Operation Warp Speed vaccine mission, advised reporters Monday.